

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.20977437 |
| 2 | microglial cell activation (GO:0001774) | 4.93845928 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.83981799 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.83981799 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.83981799 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.83981799 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.83981799 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.83981799 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 4.67950665 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 4.49298310 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.23851806 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 4.23407082 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11365250 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.08816506 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99325259 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.97790638 |
| 17 | macrophage activation (GO:0042116) | 3.94140904 |
| 18 | interferon-gamma production (GO:0032609) | 3.94064052 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83127989 |
| 20 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.82988195 |
| 21 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.81205456 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.72310141 |
| 23 | neutrophil mediated immunity (GO:0002446) | 3.66702411 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63430385 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62839705 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62839705 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58013592 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56186726 |
| 29 | leukocyte aggregation (GO:0070486) | 3.51234124 |
| 30 | response to interleukin-15 (GO:0070672) | 3.44644472 |
| 31 | regulation of necroptotic process (GO:0060544) | 3.43244253 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.43197005 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.43197005 |
| 34 | response to host immune response (GO:0052572) | 3.42388919 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42388919 |
| 36 | myeloid leukocyte mediated immunity (GO:0002444) | 3.38886204 |
| 37 | tolerance induction (GO:0002507) | 3.37821330 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.35372604 |
| 39 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.35277434 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.33608185 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 3.32787250 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30664610 |
| 43 | negative T cell selection (GO:0043383) | 3.26456113 |
| 44 | positive T cell selection (GO:0043368) | 3.25366862 |
| 45 | negative regulation of B cell proliferation (GO:0030889) | 3.23984302 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.23219454 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22419071 |
| 48 | response to host (GO:0075136) | 3.22419071 |
| 49 | response to host defenses (GO:0052200) | 3.22419071 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.20431897 |
| 51 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.14485012 |
| 52 | regulation of beta-amyloid formation (GO:1902003) | 3.06853148 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.06554636 |
| 54 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04750276 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.00602365 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 3.00581571 |
| 57 | activated T cell proliferation (GO:0050798) | 2.98775352 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98459770 |
| 59 | presynaptic membrane organization (GO:0097090) | 2.98354020 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 2.97638349 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.95951292 |
| 62 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92437585 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92437585 |
| 64 | regulation of platelet aggregation (GO:0090330) | 2.90709939 |
| 65 | negative regulation of humoral immune response (GO:0002921) | 2.89029156 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86192944 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 2.85104345 |
| 68 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.83676236 |
| 69 | negative regulation of B cell mediated immunity (GO:0002713) | 2.83676236 |
| 70 | cellular response to zinc ion (GO:0071294) | 2.83013023 |
| 71 | cellular response to ethanol (GO:0071361) | 2.81488185 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80617640 |
| 73 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.78359486 |
| 74 | negative regulation of adaptive immune response (GO:0002820) | 2.77947333 |
| 75 | T cell migration (GO:0072678) | 2.76528600 |
| 76 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.73075032 |
| 77 | T cell selection (GO:0045058) | 2.72895319 |
| 78 | thymic T cell selection (GO:0045061) | 2.71372903 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.70737146 |
| 80 | establishment of protein localization to Golgi (GO:0072600) | 2.70151964 |
| 81 | protein targeting to Golgi (GO:0000042) | 2.69558379 |
| 82 | positive regulation of interferon-alpha production (GO:0032727) | 2.69558246 |
| 83 | positive regulation of tolerance induction (GO:0002645) | 2.69272411 |
| 84 | regulation of actin filament-based movement (GO:1903115) | 2.67378804 |
| 85 | dendritic cell migration (GO:0036336) | 2.66693974 |
| 86 | respiratory burst (GO:0045730) | 2.65208619 |
| 87 | regulation of granulocyte differentiation (GO:0030852) | 2.64178093 |
| 88 | T cell receptor signaling pathway (GO:0050852) | 2.64035456 |
| 89 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.63960093 |
| 90 | response to peptidoglycan (GO:0032494) | 2.62985166 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62775231 |
| 92 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.62515978 |
| 93 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.61966312 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.61534366 |
| 95 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60731692 |
| 96 | histone H3-K4 trimethylation (GO:0080182) | 2.60485797 |
| 97 | positive regulation of interleukin-2 production (GO:0032743) | 2.58982884 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58425049 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56555357 |
| 100 | regulation of T cell tolerance induction (GO:0002664) | 2.54281954 |
| 101 | regulation of cell communication by electrical coupling (GO:0010649) | 2.53928221 |
| 102 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.53451228 |
| 103 | mast cell activation (GO:0045576) | 2.51043730 |
| 104 | creatine metabolic process (GO:0006600) | 2.49604264 |
| 105 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.48679382 |
| 106 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.47044502 |
| 107 | phagocytosis, recognition (GO:0006910) | 2.45869271 |
| 108 | positive regulation of B cell differentiation (GO:0045579) | 2.45748435 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44232854 |
| 110 | regulation of regulatory T cell differentiation (GO:0045589) | 2.42737988 |
| 111 | detection of bacterium (GO:0016045) | 2.41203654 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.40381061 |
| 113 | cellular response to epinephrine stimulus (GO:0071872) | 2.40339188 |
| 114 | negative regulation of complement activation (GO:0045916) | 2.39891786 |
| 115 | detection of other organism (GO:0098543) | 2.38754144 |
| 116 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.37773684 |
| 117 | regulation of tolerance induction (GO:0002643) | 2.37473484 |
| 118 | megakaryocyte development (GO:0035855) | 2.37322908 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.36859536 |
| 120 | membrane raft organization (GO:0031579) | 2.33674311 |
| 121 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.31223701 |
| 122 | presynaptic membrane assembly (GO:0097105) | 2.31066468 |
| 123 | histone H3-K36 demethylation (GO:0070544) | 2.29302690 |
| 124 | neutrophil activation (GO:0042119) | 2.28567620 |
| 125 | response to epinephrine (GO:0071871) | 2.27749110 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.27318222 |
| 127 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.24559841 |
| 128 | T cell costimulation (GO:0031295) | 2.21430360 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.21132328 |
| 130 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.21132328 |
| 131 | response to type I interferon (GO:0034340) | 2.20012087 |
| 132 | lymphocyte costimulation (GO:0031294) | 2.19788501 |
| 133 | oxygen transport (GO:0015671) | 2.19264652 |
| 134 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.19259439 |
| 135 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.19259439 |
| 136 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.18843880 |
| 137 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.18639987 |
| 138 | cellular extravasation (GO:0045123) | 2.17720431 |
| 139 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.17018715 |
| 140 | cellular response to type I interferon (GO:0071357) | 2.15811574 |
| 141 | type I interferon signaling pathway (GO:0060337) | 2.15811574 |
| 142 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.14501406 |
| 143 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.13413035 |
| 144 | leukocyte homeostasis (GO:0001776) | 2.12477082 |
| 145 | negative regulation of T cell apoptotic process (GO:0070233) | 2.11859246 |
| 146 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.10957676 |
| 147 | definitive hemopoiesis (GO:0060216) | 2.10935515 |
| 148 | leukocyte cell-cell adhesion (GO:0007159) | 2.10275282 |
| 149 | T-helper cell differentiation (GO:0042093) | 2.09773859 |
| 150 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.09773859 |
| 151 | lymphocyte homeostasis (GO:0002260) | 2.04913044 |
| 152 | negative regulation of protein activation cascade (GO:2000258) | 2.04640474 |
| 153 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.04088903 |
| 154 | germinal center formation (GO:0002467) | 2.03863001 |
| 155 | negative regulation of monooxygenase activity (GO:0032769) | 2.02112609 |
| 156 | lymph node development (GO:0048535) | 2.01195720 |
| 157 | regulation of sarcomere organization (GO:0060297) | 2.00235806 |
| 158 | angiogenesis involved in wound healing (GO:0060055) | 2.00215848 |
| 159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.00048412 |
| 160 | regulation of interleukin-2 production (GO:0032663) | 1.99768860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.95873167 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.39533480 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.30277342 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.93951557 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.61390013 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58180636 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55683845 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.38404333 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.37932809 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.32708518 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30825103 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29218928 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11154117 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96796177 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87510143 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86995682 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84091370 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82361732 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80962841 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79065171 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76650527 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63399189 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62989164 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61274149 |
| 25 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.56710501 |
| 26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56627727 |
| 27 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56138164 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55994546 |
| 29 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.55254997 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.51071187 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47853143 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47242481 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47202210 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46890484 |
| 35 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43988635 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42563802 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38487744 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.36733547 |
| 39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.33694598 |
| 40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.31248306 |
| 41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26400401 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.26117478 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22321154 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22236726 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16386740 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15878044 |
| 47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14278996 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13724915 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13672764 |
| 50 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12714544 |
| 51 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12205223 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11049069 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10177374 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08958191 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08367608 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.07163448 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07007700 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06688062 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06668054 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05544858 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03091662 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02135055 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01936238 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00498857 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99676464 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99138356 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98864846 |
| 68 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97559121 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96932169 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96629047 |
| 71 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96067988 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95915024 |
| 73 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95189531 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93479370 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93276305 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93194138 |
| 77 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92484756 |
| 78 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91441883 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90178966 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89284476 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88880138 |
| 82 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88711287 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88711287 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87229138 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87194746 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86472414 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85653945 |
| 88 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85501980 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84083245 |
| 90 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.83652668 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83355679 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82915968 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82891811 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82727505 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81987917 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81878912 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.81851802 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81848431 |
| 99 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81219052 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80371056 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80010930 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79789712 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79235791 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79235791 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79200907 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79107612 |
| 107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.78429537 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77944621 |
| 109 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.77776643 |
| 110 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.77314565 |
| 111 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77263881 |
| 112 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76989513 |
| 113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76834969 |
| 114 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75680037 |
| 115 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75261085 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.74912990 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74780868 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73784873 |
| 119 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73448521 |
| 120 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73363360 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73345750 |
| 122 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.73328051 |
| 123 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.73158046 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72470530 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72233816 |
| 126 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72017254 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71856875 |
| 128 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71768002 |
| 129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.71731485 |
| 130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70921111 |
| 131 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.70343708 |
| 132 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.69519028 |
| 133 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.68744107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.12211668 |
| 2 | MP0005671_abnormal_response_to | 3.11465255 |
| 3 | MP0004147_increased_porphyrin_level | 3.08917269 |
| 4 | MP0003724_increased_susceptibility_to | 2.74693895 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.73862426 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.58210597 |
| 7 | MP0001790_abnormal_immune_system | 2.49562009 |
| 8 | MP0005387_immune_system_phenotype | 2.49562009 |
| 9 | MP0003303_peritoneal_inflammation | 2.45802503 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.31903602 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.31459901 |
| 12 | MP0000685_abnormal_immune_system | 2.30294347 |
| 13 | MP0001800_abnormal_humoral_immune | 2.29044809 |
| 14 | MP0009785_altered_susceptibility_to | 2.25351400 |
| 15 | MP0005451_abnormal_body_composition | 2.22691992 |
| 16 | MP0003646_muscle_fatigue | 2.20334637 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.14642636 |
| 18 | MP0002723_abnormal_immune_serum | 2.01931750 |
| 19 | MP0002419_abnormal_innate_immunity | 1.97605038 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.94312409 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.92915267 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.91870469 |
| 23 | MP0001819_abnormal_immune_cell | 1.87582105 |
| 24 | MP0002933_joint_inflammation | 1.86775470 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.86661835 |
| 26 | MP0005025_abnormal_response_to | 1.84628636 |
| 27 | MP0003787_abnormal_imprinting | 1.80866684 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.72061820 |
| 29 | MP0003436_decreased_susceptibility_to | 1.70750239 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.69014207 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.68548910 |
| 32 | MP0004130_abnormal_muscle_cell | 1.67844501 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.67141722 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.65781050 |
| 35 | MP0000343_altered_response_to | 1.62886292 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.61235654 |
| 37 | MP0004484_altered_response_of | 1.60706135 |
| 38 | MP0008057_abnormal_DNA_replication | 1.57596062 |
| 39 | MP0000749_muscle_degeneration | 1.56586812 |
| 40 | MP0003828_pulmonary_edema | 1.55449940 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.55210809 |
| 42 | MP0002009_preneoplasia | 1.51784928 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.51276156 |
| 44 | MP0001853_heart_inflammation | 1.49087353 |
| 45 | MP0000920_abnormal_myelination | 1.47434024 |
| 46 | MP0000716_abnormal_immune_system | 1.46327997 |
| 47 | MP0002398_abnormal_bone_marrow | 1.45278437 |
| 48 | MP0001873_stomach_inflammation | 1.44419352 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.40128420 |
| 50 | MP0008260_abnormal_autophagy | 1.39843905 |
| 51 | MP0002405_respiratory_system_inflammati | 1.39581950 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.37458964 |
| 53 | MP0005310_abnormal_salivary_gland | 1.37331922 |
| 54 | MP0002006_tumorigenesis | 1.36629096 |
| 55 | MP0004510_myositis | 1.36597876 |
| 56 | MP0009764_decreased_sensitivity_to | 1.31842543 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.31359909 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.31008164 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.30729982 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.30165764 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.29782632 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.29782632 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.26737548 |
| 64 | MP0006082_CNS_inflammation | 1.26019777 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.23453796 |
| 66 | MP0004947_skin_inflammation | 1.22738591 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.21887453 |
| 68 | MP0003690_abnormal_glial_cell | 1.19785381 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.19441512 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.17934207 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.17483285 |
| 72 | MP0002429_abnormal_blood_cell | 1.16313461 |
| 73 | MP0002722_abnormal_immune_system | 1.16143443 |
| 74 | MP0006054_spinal_hemorrhage | 1.14154140 |
| 75 | MP0003279_aneurysm | 1.12209190 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 1.09744477 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.09722625 |
| 78 | MP0008469_abnormal_protein_level | 1.09186781 |
| 79 | MP0000751_myopathy | 1.06414636 |
| 80 | MP0008004_abnormal_stomach_pH | 1.04512422 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.04389955 |
| 82 | MP0002132_abnormal_respiratory_system | 1.04074580 |
| 83 | MP0000858_altered_metastatic_potential | 1.03454882 |
| 84 | MP0005330_cardiomyopathy | 1.02631254 |
| 85 | MP0003091_abnormal_cell_migration | 1.02577833 |
| 86 | MP0001851_eye_inflammation | 1.01627519 |
| 87 | MP0004381_abnormal_hair_follicle | 0.98437212 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.97345026 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.95062116 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.94263439 |
| 91 | MP0003866_abnormal_defecation | 0.91784074 |
| 92 | MP0005083_abnormal_biliary_tract | 0.91372184 |
| 93 | MP0001542_abnormal_bone_strength | 0.89384076 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.88431533 |
| 95 | MP0003045_fibrosis | 0.88073951 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.88008520 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.87137967 |
| 98 | MP0000371_diluted_coat_color | 0.86530867 |
| 99 | MP0008874_decreased_physiological_sensi | 0.84908013 |
| 100 | MP0008569_lethality_at_weaning | 0.84523564 |
| 101 | MP0005620_abnormal_muscle_contractility | 0.84303539 |
| 102 | MP0009278_abnormal_bone_marrow | 0.83831286 |
| 103 | MP0004883_abnormal_blood_vessel | 0.82648300 |
| 104 | MP0005165_increased_susceptibility_to | 0.82316173 |
| 105 | MP0009763_increased_sensitivity_to | 0.81221640 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.80558059 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.79882644 |
| 108 | MP0000249_abnormal_blood_vessel | 0.79859956 |
| 109 | MP0001544_abnormal_cardiovascular_syste | 0.77998804 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.77998804 |
| 111 | MP0000604_amyloidosis | 0.77645633 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.77028067 |
| 113 | MP0002735_abnormal_chemical_nociception | 0.76774470 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.75627260 |
| 115 | MP0008995_early_reproductive_senescence | 0.73594231 |
| 116 | MP0005388_respiratory_system_phenotype | 0.71567841 |
| 117 | MP0002133_abnormal_respiratory_system | 0.71567841 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.71004351 |
| 119 | MP0005164_abnormal_response_to | 0.70933022 |
| 120 | MP0004087_abnormal_muscle_fiber | 0.70753192 |
| 121 | MP0004085_abnormal_heartbeat | 0.70721842 |
| 122 | MP0003075_altered_response_to | 0.70679018 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.70638145 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69995171 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.69030941 |
| 126 | MP0005266_abnormal_metabolism | 0.68837569 |
| 127 | MP0001958_emphysema | 0.67416111 |
| 128 | MP0009115_abnormal_fat_cell | 0.63022950 |
| 129 | MP0000427_abnormal_hair_cycle | 0.61971478 |
| 130 | MP0005409_darkened_coat_color | 0.58359266 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.58274775 |
| 132 | MP0002277_abnormal_respiratory_mucosa | 0.58011094 |
| 133 | MP0001915_intracranial_hemorrhage | 0.57311539 |
| 134 | MP0005621_abnormal_cell_physiology | 0.54831397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.14456414 |
| 2 | Gastrointestinal infarctions (HP:0005244) | 4.12441897 |
| 3 | Exercise-induced myalgia (HP:0003738) | 3.50617517 |
| 4 | Agammaglobulinemia (HP:0004432) | 3.42023655 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 3.41655785 |
| 6 | Stomatitis (HP:0010280) | 3.33791177 |
| 7 | Gingivitis (HP:0000230) | 3.20108385 |
| 8 | Recurrent sinusitis (HP:0011108) | 3.15242435 |
| 9 | Myositis (HP:0100614) | 3.06884539 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 3.06069983 |
| 11 | Subacute progressive viral hepatitis (HP:0006572) | 3.03909338 |
| 12 | Leukocytosis (HP:0001974) | 3.03214095 |
| 13 | Slow saccadic eye movements (HP:0000514) | 3.01151165 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95516968 |
| 15 | Chest pain (HP:0100749) | 2.95209161 |
| 16 | Recurrent bronchitis (HP:0002837) | 2.94173579 |
| 17 | T lymphocytopenia (HP:0005403) | 2.91586322 |
| 18 | Spontaneous hematomas (HP:0007420) | 2.91295722 |
| 19 | Keratoconjunctivitis (HP:0001096) | 2.91213194 |
| 20 | Gastrointestinal stroma tumor (HP:0100723) | 2.90190338 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 2.90189066 |
| 22 | Recurrent fungal infections (HP:0002841) | 2.89861624 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88485707 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88485707 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.85775561 |
| 26 | Peritonitis (HP:0002586) | 2.83937140 |
| 27 | Abnormality of T cell number (HP:0011839) | 2.82062284 |
| 28 | Chronic otitis media (HP:0000389) | 2.80160214 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.79720769 |
| 30 | Papillary thyroid carcinoma (HP:0002895) | 2.78519586 |
| 31 | Urticaria (HP:0001025) | 2.75231260 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.72908604 |
| 33 | Abnormality of the fingertips (HP:0001211) | 2.72740475 |
| 34 | Optic neuritis (HP:0100653) | 2.72241340 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.72241340 |
| 36 | Hypochromic anemia (HP:0001931) | 2.72139408 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.69103012 |
| 38 | Stomach cancer (HP:0012126) | 2.66916430 |
| 39 | Eosinophilia (HP:0001880) | 2.66846237 |
| 40 | Postural instability (HP:0002172) | 2.66789959 |
| 41 | Colitis (HP:0002583) | 2.65253619 |
| 42 | Ventricular tachycardia (HP:0004756) | 2.65032686 |
| 43 | IgM deficiency (HP:0002850) | 2.62085532 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.61204750 |
| 45 | Orchitis (HP:0100796) | 2.58227035 |
| 46 | EMG: myopathic abnormalities (HP:0003458) | 2.57102702 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.54942544 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.54595943 |
| 49 | Hematochezia (HP:0002573) | 2.54327594 |
| 50 | Chronic sinusitis (HP:0011109) | 2.51445199 |
| 51 | Meningitis (HP:0001287) | 2.49320050 |
| 52 | Abnormality of the nasal mucosa (HP:0000433) | 2.47723905 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.46384147 |
| 54 | Thyroid-stimulating hormone excess (HP:0002925) | 2.44266570 |
| 55 | Renal cortical cysts (HP:0000803) | 2.42875633 |
| 56 | Chronic diarrhea (HP:0002028) | 2.40733310 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.39962260 |
| 58 | Microcytic anemia (HP:0001935) | 2.39456869 |
| 59 | Increased IgE level (HP:0003212) | 2.39094370 |
| 60 | Viral hepatitis (HP:0006562) | 2.39013674 |
| 61 | Epistaxis (HP:0000421) | 2.35286770 |
| 62 | Purpura (HP:0000979) | 2.34744688 |
| 63 | Granulocytopenia (HP:0001913) | 2.33466608 |
| 64 | Obstructive lung disease (HP:0006536) | 2.33404145 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33404145 |
| 66 | Atrial fibrillation (HP:0005110) | 2.33208501 |
| 67 | Hemoptysis (HP:0002105) | 2.31740074 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.30628425 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.29029828 |
| 70 | Recurrent viral infections (HP:0004429) | 2.27418326 |
| 71 | Easy fatigability (HP:0003388) | 2.25842940 |
| 72 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.25038950 |
| 73 | Asymmetric septal hypertrophy (HP:0001670) | 2.24673533 |
| 74 | Abnormal hair whorl (HP:0010721) | 2.24351104 |
| 75 | Vasculitis (HP:0002633) | 2.23727387 |
| 76 | Anorexia (HP:0002039) | 2.23617873 |
| 77 | Nasal polyposis (HP:0100582) | 2.23096394 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.22793734 |
| 79 | Cellulitis (HP:0100658) | 2.19885090 |
| 80 | Exercise-induced muscle cramps (HP:0003710) | 2.19712650 |
| 81 | Recurrent skin infections (HP:0001581) | 2.18003925 |
| 82 | Muscle fiber splitting (HP:0003555) | 2.16896537 |
| 83 | Lipoatrophy (HP:0100578) | 2.16312044 |
| 84 | Pustule (HP:0200039) | 2.14123154 |
| 85 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13732774 |
| 86 | Pulmonary embolism (HP:0002204) | 2.13121940 |
| 87 | Episodic fever (HP:0001954) | 2.12412572 |
| 88 | Papilloma (HP:0012740) | 2.12071519 |
| 89 | Verrucae (HP:0200043) | 2.12071519 |
| 90 | Difficulty running (HP:0009046) | 2.10608847 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.09102245 |
| 92 | Petechiae (HP:0000967) | 2.08628899 |
| 93 | Gingival bleeding (HP:0000225) | 2.07949587 |
| 94 | Poikilocytosis (HP:0004447) | 2.07204614 |
| 95 | White forelock (HP:0002211) | 2.07088252 |
| 96 | Gangrene (HP:0100758) | 2.05831689 |
| 97 | Osteomyelitis (HP:0002754) | 2.05271891 |
| 98 | Sudden death (HP:0001699) | 2.03631373 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 2.03490373 |
| 100 | Bronchitis (HP:0012387) | 2.03327676 |
| 101 | Dilated cardiomyopathy (HP:0001644) | 2.02543686 |
| 102 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02412348 |
| 103 | Periodontitis (HP:0000704) | 2.01166930 |
| 104 | Nemaline bodies (HP:0003798) | 2.00440553 |
| 105 | Abnormality of T cells (HP:0002843) | 1.99684110 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 1.97671308 |
| 107 | Supraventricular tachycardia (HP:0004755) | 1.97390541 |
| 108 | Central scotoma (HP:0000603) | 1.96983457 |
| 109 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.96803791 |
| 110 | Encephalitis (HP:0002383) | 1.96524309 |
| 111 | Patchy hypopigmentation of hair (HP:0011365) | 1.96362708 |
| 112 | Abnormality of macrophages (HP:0004311) | 1.96311640 |
| 113 | Onycholysis (HP:0001806) | 1.96144391 |
| 114 | Myoglobinuria (HP:0002913) | 1.95032822 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.94801610 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94119316 |
| 117 | Conjunctival telangiectasia (HP:0000524) | 1.93150516 |
| 118 | Weak cry (HP:0001612) | 1.93120123 |
| 119 | Muscle fiber inclusion bodies (HP:0100299) | 1.92836284 |
| 120 | Hyperkalemia (HP:0002153) | 1.92638518 |
| 121 | Bulbar palsy (HP:0001283) | 1.92035937 |
| 122 | Arterial thrombosis (HP:0004420) | 1.90704590 |
| 123 | Mitral stenosis (HP:0001718) | 1.89967030 |
| 124 | Hypoplasia of the thymus (HP:0000778) | 1.89606130 |
| 125 | Acute hepatic failure (HP:0006554) | 1.89476431 |
| 126 | Supraventricular arrhythmia (HP:0005115) | 1.88491458 |
| 127 | Alveolar cell carcinoma (HP:0006519) | 1.87801701 |
| 128 | Visual hallucinations (HP:0002367) | 1.86640334 |
| 129 | Abnormality of the endocardium (HP:0004306) | 1.86621255 |
| 130 | Recurrent bacterial skin infections (HP:0005406) | 1.85711149 |
| 131 | Hepatosplenomegaly (HP:0001433) | 1.85100241 |
| 132 | Congenital stationary night blindness (HP:0007642) | 1.84445011 |
| 133 | Hyporeflexia of lower limbs (HP:0002600) | 1.84326523 |
| 134 | IgG deficiency (HP:0004315) | 1.83569061 |
| 135 | Subaortic stenosis (HP:0001682) | 1.82475164 |
| 136 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82475164 |
| 137 | Cholelithiasis (HP:0001081) | 1.82121229 |
| 138 | Abnormality of the peritoneum (HP:0002585) | 1.80393081 |
| 139 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.78737703 |
| 140 | Interstitial pulmonary disease (HP:0006530) | 1.78690002 |
| 141 | Cerebral palsy (HP:0100021) | 1.78647488 |
| 142 | Lymphopenia (HP:0001888) | 1.78185809 |
| 143 | Retinal atrophy (HP:0001105) | 1.78126757 |
| 144 | Toxemia of pregnancy (HP:0100603) | 1.78016031 |
| 145 | Abnormality of eosinophils (HP:0001879) | 1.76746440 |
| 146 | Joint swelling (HP:0001386) | 1.75489555 |
| 147 | Thyroiditis (HP:0100646) | 1.75489054 |
| 148 | Thyroid carcinoma (HP:0002890) | 1.75158981 |
| 149 | Genetic anticipation (HP:0003743) | 1.73808604 |
| 150 | Thrombophlebitis (HP:0004418) | 1.71936691 |
| 151 | Vertigo (HP:0002321) | 1.71157486 |
| 152 | Fatigue (HP:0012378) | 1.71144071 |
| 153 | Ocular albinism (HP:0001107) | 1.71027864 |
| 154 | Abnormality of the pleura (HP:0002103) | 1.69595508 |
| 155 | Glucose intolerance (HP:0000833) | 1.69334770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.37743342 |
| 2 | TXK | 3.29427550 |
| 3 | MAP4K1 | 3.04816204 |
| 4 | TGFBR2 | 2.74709198 |
| 5 | ITK | 2.20808892 |
| 6 | FRK | 2.14744681 |
| 7 | TNIK | 2.05573937 |
| 8 | EPHB1 | 2.05199213 |
| 9 | IKBKE | 1.99152135 |
| 10 | IRAK4 | 1.89627913 |
| 11 | WNK1 | 1.88807409 |
| 12 | TEC | 1.87434051 |
| 13 | NLK | 1.83896562 |
| 14 | TRPM7 | 1.82455344 |
| 15 | GRK7 | 1.82432498 |
| 16 | FGR | 1.82266434 |
| 17 | ZAP70 | 1.72118717 |
| 18 | FES | 1.70742947 |
| 19 | MYLK | 1.69193660 |
| 20 | MAP3K14 | 1.64764670 |
| 21 | TTN | 1.64383891 |
| 22 | MAP3K2 | 1.64300696 |
| 23 | TIE1 | 1.63536250 |
| 24 | MAP2K3 | 1.60462908 |
| 25 | PTK2B | 1.59857317 |
| 26 | BMPR2 | 1.58493094 |
| 27 | TBK1 | 1.57073301 |
| 28 | BTK | 1.53436010 |
| 29 | MUSK | 1.50375826 |
| 30 | JAK1 | 1.46848603 |
| 31 | MAP3K12 | 1.45549495 |
| 32 | IKBKB | 1.38436704 |
| 33 | EPHA3 | 1.36926349 |
| 34 | PRPF4B | 1.36694118 |
| 35 | TAOK1 | 1.36663457 |
| 36 | STK10 | 1.35235875 |
| 37 | TYK2 | 1.35026767 |
| 38 | PINK1 | 1.32290030 |
| 39 | GRK6 | 1.30956520 |
| 40 | MAPK12 | 1.30543775 |
| 41 | KIT | 1.29597794 |
| 42 | CSK | 1.29110798 |
| 43 | MARK2 | 1.28757176 |
| 44 | STK4 | 1.27754059 |
| 45 | MAP3K10 | 1.25937916 |
| 46 | YES1 | 1.25882977 |
| 47 | JAK3 | 1.25235593 |
| 48 | IRAK3 | 1.23533335 |
| 49 | FGFR4 | 1.22358651 |
| 50 | MST4 | 1.17914400 |
| 51 | MAP3K1 | 1.12289510 |
| 52 | GRK5 | 1.11732093 |
| 53 | STK24 | 1.07877671 |
| 54 | SYK | 1.07090625 |
| 55 | PRKCH | 1.06271509 |
| 56 | EEF2K | 1.06207166 |
| 57 | LCK | 1.06084190 |
| 58 | CAMKK2 | 1.02396695 |
| 59 | SGK2 | 1.01298228 |
| 60 | MAPK7 | 0.97671393 |
| 61 | MAP3K13 | 0.96496739 |
| 62 | AKT3 | 0.94680410 |
| 63 | HCK | 0.94680070 |
| 64 | MAP2K6 | 0.94408326 |
| 65 | HIPK2 | 0.94203355 |
| 66 | IRAK2 | 0.93353969 |
| 67 | INSRR | 0.92259057 |
| 68 | PKN1 | 0.91897408 |
| 69 | STK38 | 0.90848589 |
| 70 | SGK3 | 0.87905386 |
| 71 | MAP3K7 | 0.87601478 |
| 72 | PHKG2 | 0.86546977 |
| 73 | PHKG1 | 0.86546977 |
| 74 | CASK | 0.86111534 |
| 75 | PDK2 | 0.85829078 |
| 76 | PRKCQ | 0.85739411 |
| 77 | MAPKAPK3 | 0.83263360 |
| 78 | JAK2 | 0.82759715 |
| 79 | SGK494 | 0.82731179 |
| 80 | SGK223 | 0.82731179 |
| 81 | PIM1 | 0.78191038 |
| 82 | STK11 | 0.78029741 |
| 83 | CSF1R | 0.77856519 |
| 84 | LYN | 0.76817183 |
| 85 | PLK2 | 0.75338003 |
| 86 | MAPKAPK5 | 0.75267526 |
| 87 | IRAK1 | 0.74901399 |
| 88 | TNK2 | 0.74395297 |
| 89 | OBSCN | 0.74160016 |
| 90 | KDR | 0.72284804 |
| 91 | ERBB2 | 0.71257850 |
| 92 | SGK1 | 0.71021791 |
| 93 | SIK3 | 0.70638202 |
| 94 | LRRK2 | 0.70314183 |
| 95 | KSR2 | 0.70136024 |
| 96 | TAOK3 | 0.68721866 |
| 97 | FGFR3 | 0.68409897 |
| 98 | MAP3K5 | 0.67833814 |
| 99 | DYRK1A | 0.66843604 |
| 100 | GRK1 | 0.65754155 |
| 101 | FLT3 | 0.65237665 |
| 102 | MAP3K11 | 0.65042071 |
| 103 | CHUK | 0.63903645 |
| 104 | CDK12 | 0.61229332 |
| 105 | CAMK1D | 0.60735846 |
| 106 | DYRK1B | 0.59247656 |
| 107 | MARK3 | 0.58746251 |
| 108 | NEK6 | 0.57619216 |
| 109 | FGFR2 | 0.56363012 |
| 110 | BLK | 0.56182456 |
| 111 | PRKAA2 | 0.56144540 |
| 112 | PAK3 | 0.56077801 |
| 113 | RET | 0.54833191 |
| 114 | MATK | 0.54747142 |
| 115 | MAP2K4 | 0.54521668 |
| 116 | CDK3 | 0.54247404 |
| 117 | DMPK | 0.53213923 |
| 118 | PRKD1 | 0.53062030 |
| 119 | PRKD2 | 0.52258063 |
| 120 | CAMK4 | 0.52097223 |
| 121 | ERN1 | 0.51563295 |
| 122 | PKN2 | 0.50563471 |
| 123 | ROCK2 | 0.50468765 |
| 124 | NUAK1 | 0.50460001 |
| 125 | PDK1 | 0.50057315 |
| 126 | PDGFRB | 0.49643537 |
| 127 | MAP3K6 | 0.49139043 |
| 128 | KSR1 | 0.48914226 |
| 129 | CAMK1 | 0.48666342 |
| 130 | FYN | 0.48258690 |
| 131 | ADRBK2 | 0.47252825 |
| 132 | ACVR1B | 0.46998452 |
| 133 | MAP3K3 | 0.46362055 |
| 134 | PIK3CA | 0.44260432 |
| 135 | PIK3CG | 0.44178299 |
| 136 | MAPK15 | 0.44115483 |
| 137 | NEK9 | 0.43745763 |
| 138 | RAF1 | 0.42675897 |
| 139 | RPS6KA6 | 0.42240460 |
| 140 | MAPK4 | 0.41504304 |
| 141 | IGF1R | 0.41261135 |
| 142 | CLK1 | 0.39803845 |
| 143 | PRKCE | 0.39702664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.48630337 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60967154 |
| 3 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.91263575 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89069433 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86551620 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.82344438 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82037060 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81638269 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78992519 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76992991 |
| 11 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.76636315 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.75613441 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69542219 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69168195 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68965705 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.68696756 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.61131486 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.54870083 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.49766181 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38398558 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35575656 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33780518 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.32118538 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31853636 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30416066 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27824812 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.25728302 |
| 28 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.21610207 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21538138 |
| 30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.21407726 |
| 31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19702969 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19483197 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19041231 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17147479 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.15804642 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15196674 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14676260 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12435262 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10960300 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10678932 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07587453 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.06933731 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05254112 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04962610 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04845286 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.03151506 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03003060 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00529973 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99685274 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99451927 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99304955 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.97697588 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96137224 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.95412272 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94984942 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94047322 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93724640 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93420640 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93334085 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93189158 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89316296 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88958959 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87101574 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85972300 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85882588 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.85775035 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84709064 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83395545 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83035520 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82783160 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82724209 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82487450 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.79373794 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78522933 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77493130 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.77329319 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.77001991 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75891186 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75855539 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75221820 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75099078 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74411223 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.74343769 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.73505970 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73314697 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.73229310 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72996006 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71476673 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70640713 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70417736 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.70333000 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.69753933 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69570903 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68755994 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68748675 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.68185132 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68001565 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67667797 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67262037 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67012710 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64472713 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63447118 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63421631 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62594115 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62379048 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61761459 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.60424013 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.59508078 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59494654 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.59329171 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57661358 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57429657 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55374761 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55250023 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54337023 |
| 116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54179196 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54080174 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53123316 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.52919495 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52459367 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52340372 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49592513 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49263769 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48575034 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48308205 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47918679 |
| 127 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47532148 |
| 128 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47208612 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46873257 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.46296999 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45312507 |
| 132 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44642048 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43092290 |
| 134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42978151 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42853325 |
| 136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42585421 |
| 137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42142124 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.41866408 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.40080508 |
| 140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39919776 |
| 141 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39912482 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38548728 |
| 143 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38112177 |
| 144 | Hepatitis B_Homo sapiens_hsa05161 | 0.37844887 |
| 145 | Legionellosis_Homo sapiens_hsa05134 | 0.37387177 |
| 146 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37320061 |
| 147 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36987323 |

